Sabinsa Corporation, East Windsor, NJ, has obtained U.S. patent #8,003,614 B2, for an invention describing selenium containing dipeptides. The patent deals with the process of manufacturing pharmaceutical and cosmeceutical applications of small peptides incorporating selenium. New products, namely selenodipeptides, based upon the patent will expand the applications of selenium, an essential element for human nutrition and one in which people could be deficient.